EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Genotoxicity risk assessment of a 7-hydroxymitragynine-enriched Kratom preparation: An integrated in silico and in vitro approach

Nathaphat Harnkit, Tiyanee Sahad, Ittiya Noonate, Phatiphan Primpai, Sarayut Radapong, Weerachai Pipatrattanaseree, Pornchai Sincharoenpokai, Pramote Chamnanpuen

Toxicology Reports · 2026-06 · 16 · 102206

DOI: 10.1016/j.toxrep.2026.102206 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Toxicology Reports, 2026-06. Verfasst von Nathaphat Harnkit und 7 weiteren Autor:innen. Beteiligte Einrichtung: Toxicology Laboratory, Medicinal Plant Research Institute, Department of Medical Science, Ministry of Public Health, Nonthaburi 11000, Thailand. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 44 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: Faculty of Science, Kasetsart University.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The increasing global use of Mitragyna speciosa (Kratom) necessitates a thorough safety assessment, particularly regarding the genotoxic potential of its key alkaloids. This study employed an integrated in silico and in vitro approach to evaluate the genotoxicity of a well-characterized, semi-synthetically enhanced Kratom preparation (SKP) enriched in 7-hydroxymitragynine (7-OHMG; 56.31 % of total composition). Computational predictions using the OECD QSAR Toolbox and VEGA-QSAR platform indicated a lack of genotoxic activity for the major Kratom alkaloids (mitragynine, paynantheine, speciogynine, 7-hydroxymitragynine, and speciociliatine) across various in vitro and in vivo endpoints. However, several DNA-binding structural alerts were identified, particularly under metabolic activation, and prediction reliability ranged from low to moderate. To empirically verify these findings, an in vitro cytokinesis-block micronucleus (CBMN) assay was conducted in human TK6 cells following OECD Test Guideline 487. The extract induced concentration-dependent cytotoxicity. A statistically significant increase in micronucleus frequency was observed only at the highest concentration tested (125 µg/mL) under short-term (4 h) exposure conditions, both with and without S9 metabolic activation. Excessive cytotoxicity prevented analysis at high concentrations during long-term (24 h) exposure. Importantly, a complementary bacterial reverse mutation assay (Ames test) conducted on the identical extract showed no mutagenic activity up to 5000 µg/plate across five strains. In conclusion, while a weak positive chromosomal effect was noted at a highly cytotoxic concentration, the overall weight of evidence-including negative in silico predictions, negative Ames results, and limited in vitro micronucleus response-suggests that this 7-OHMG-enriched Kratom preparation does not present a significant genotoxic hazard under the conditions tested. This study underscores the value of a combined computational and experimental workflow for the robust genotoxicity assessment of complex natural products.

Schlagwörter

Stichwörter der Autor:innen

GenotoxicityKratomKratom’s alkaloidsMicronucleus

Autor:innen und Institutionen

  • Toxicology Laboratory, Medicinal Plant Research Institute, Department of Medical Science, Ministry of Public Health, Nonthaburi 11000, Thailand.
  • Regional Medical Sciences Center 12 Songkhla, Department of Medical Science, Ministry of Public Health, Songkhla 90100, Thailand.
  • Department of Zoology, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
  • Kasetsart University International College (KUIC), Kasetsart University, Bangkok 10900, Thailand.

Förderung

  • Faculty of Science, Kasetsart University

Zitieren

APA

Harnkit, N., Sahad, T., Noonate, I., Primpai, P., Radapong, S., Pipatrattanaseree, W., Sincharoenpokai, P., & Chamnanpuen, P. (2026). Genotoxicity risk assessment of a 7-hydroxymitragynine-enriched Kratom preparation: An integrated in silico and in vitro approach. Toxicology Reports, 16, 102206. https://doi.org/10.1016/j.toxrep.2026.102206

Vancouver

Harnkit N, Sahad T, Noonate I, Primpai P, Radapong S, Pipatrattanaseree W, et al. Genotoxicity risk assessment of a 7-hydroxymitragynine-enriched Kratom preparation: An integrated in silico and in vitro approach. Toxicology Reports. 2026;16:102206. doi:10.1016/j.toxrep.2026.102206

BibTeX
@article{Harnkit2026,
  author = {Harnkit, Nathaphat and Sahad, Tiyanee and Noonate, Ittiya and Primpai, Phatiphan and Radapong, Sarayut and Pipatrattanaseree, Weerachai and Sincharoenpokai, Pornchai and Chamnanpuen, Pramote},
  title = {Genotoxicity risk assessment of a 7-hydroxymitragynine-enriched Kratom preparation: An integrated in silico and in vitro approach},
  journal = {Toxicology Reports},
  year = {2026},
  volume = {16},
  pages = {102206},
  doi = {10.1016/j.toxrep.2026.102206}
}
Kostenlos starten →